ALZN
Price
$2.54
Change
+$0.05 (+2.00%)
Updated
Sep 18, 01:51 PM (EDT)
Capitalization
8.23M
MDGL
Price
$431.80
Change
+$14.37 (+3.44%)
Updated
Sep 18, 01:11 PM (EDT)
Capitalization
9.52B
42 days until earnings call
Interact to see
Advertisement

ALZN vs MDGL

Header iconALZN vs MDGL Comparison
Open Charts ALZN vs MDGLBanner chart's image
Alzamend Neuro
Price$2.54
Change+$0.05 (+2.00%)
Volume$500
Capitalization8.23M
Madrigal Pharmaceuticals
Price$431.80
Change+$14.37 (+3.44%)
Volume$200
Capitalization9.52B
ALZN vs MDGL Comparison Chart in %
Loading...
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALZN vs. MDGL commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALZN is a Hold and MDGL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (ALZN: $2.47 vs. MDGL: $417.43)
Brand notoriety: ALZN and MDGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALZN: 109% vs. MDGL: 70%
Market capitalization -- ALZN: $8.23M vs. MDGL: $9.52B
ALZN [@Biotechnology] is valued at $8.23M. MDGL’s [@Biotechnology] market capitalization is $9.52B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALZN’s FA Score shows that 1 FA rating(s) are green whileMDGL’s FA Score has 1 green FA rating(s).

  • ALZN’s FA Score: 1 green, 4 red.
  • MDGL’s FA Score: 1 green, 4 red.
According to our system of comparison, MDGL is a better buy in the long-term than ALZN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALZN’s TA Score shows that 3 TA indicator(s) are bullish while MDGL’s TA Score has 4 bullish TA indicator(s).

  • ALZN’s TA Score: 3 bullish, 4 bearish.
  • MDGL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MDGL is a better buy in the short-term than ALZN.

Price Growth

ALZN (@Biotechnology) experienced а +5.11% price change this week, while MDGL (@Biotechnology) price change was -2.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.40%. For the same industry, the average monthly price growth was +12.19%, and the average quarterly price growth was +39.12%.

Reported Earning Dates

MDGL is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.40% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDGL($9.52B) has a higher market cap than ALZN($8.23M). MDGL YTD gains are higher at: 35.279 vs. ALZN (-76.341). ALZN has higher annual earnings (EBITDA): -4.16M vs. MDGL (-266.74M). MDGL has more cash in the bank: 797M vs. ALZN (3.36M). ALZN has less debt than MDGL: ALZN (301K) vs MDGL (124M). MDGL has higher revenues than ALZN: MDGL (516M) vs ALZN (0).
ALZNMDGLALZN / MDGL
Capitalization8.23M9.52B0%
EBITDA-4.16M-266.74M2%
Gain YTD-76.34135.279-216%
P/E RatioN/AN/A-
Revenue0516M-
Total Cash3.36M797M0%
Total Debt301K124M0%
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
29
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALZNMDGL
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 11 days ago
78%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 4 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LICQX18.14N/A
N/A
Lord Abbett International Equity R2
NSIDX15.15N/A
N/A
Northern Small Cap Index
ASMNX22.07N/A
N/A
AQR Small Cap Momentum Style N
SVFYX83.08N/A
N/A
Smead Value Y
GFAFX87.11-0.42
-0.48%
American Funds Growth Fund of Amer F1

MDGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with ALXO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then ALXO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDGL
1D Price
Change %
MDGL100%
-2.25%
ALXO - MDGL
56%
Loosely correlated
-1.39%
NAGE - MDGL
45%
Loosely correlated
+1.53%
IPHA - MDGL
44%
Loosely correlated
-3.85%
RNAC - MDGL
43%
Loosely correlated
-4.79%
GHRS - MDGL
43%
Loosely correlated
-1.74%
More